stay tuned:
elixi news from the
world

We are a Swiss pharmaceutical wholesaler, specialized in sourcing and delivering pharma products, medical devices and drugs from and to all over the world.

Enspryng (satralizumab), new treatment for rare autoimmune disease of nerve cells

27 Aprile 2021

EMA has recommended granting a marketing authorisation in the European Union (EU) for Enspryng (satralizumab) for the treatment of neuromyelitis optica spectrum disorders (NMOSD) in adults and

[ More ]